FDA Approved: IMULDOSA — Supplemental Application (Accord BioPharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for IMULDOSA (USTEKINUMAB-SRLF) from Accord BioPharma Inc. The action updates the regulatory status of the product as pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Plaque Psoriasis
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• IMULDOSA (ustekinumab-srlf)

Snippet

SUPPL AP for IMULDOSA (USTEKINUMAB-SRLF)